OrbiMed Advisors LLC's Form 4 filing
BlossomHill Therapeutics, Inc. (BLSM) · filed Aug 12, 2026
- Accession no.
- 0000947871-26-000784
- Filed
- Aug 12, 2026, 4:43 PM ET
- Trade date
- Aug 10, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $10.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | Director |
| OrbiMed Capital GP VIII LLCCIK 0001845804 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | CConversionAcquired | +1,039,996 | – | – | 1,039,996 | Indirect | |
| Aug 10, 2026 | Common Stock | CConversionAcquired | +1,049,283 | – | – | 2,089,279 | Indirect | |
| Aug 10, 2026 | Common Stock | PPurchaseAcquired | +625,000 | $16.00 | +$10,000,000 | 2,714,279 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | CConversionDisposed | −1,039,996 | $0.00 | $0 | 0 | Indirect | |
| Aug 10, 2026 | Common Stock | CConversionDisposed | −1,049,283 | $0.00 | $0 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.